Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD
- PMID: 26698843
- DOI: 10.1136/annrheumdis-2015-208491
Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD
Abstract
Background: We aimed to describe the main features of Behçet's disease (BD) in children in the largest prospective cohort to date and to propose a classification.
Methods: An international expert consensus group was formed to define a data set of minimal symptoms for the inclusion of patients. Patients were entered prospectively during 66 months. Experts classified patients on a consensus basis. The concordance of two international classifications was analysed in confirmed patients with BD. Comparisons of subgroups of patients helped define consensus criteria. BD-associated clinical manifestations were also investigated in three control diseases extracted from an independent data set (Eurofever).
Findings: In total, 42 centres from 12 countries included 230 patients; data for 219 (M/F ratio=1) could be analysed. The experts classified 156 patients (71.2%) as having confirmed BD. Males more often than females showed cutaneous, ocular and vascular symptoms and females more often genital aphthosis. Age at disease onset and skin and vascular involvement were lower for European than non-European children. Oral aphthosis was the presenting sign for 81% (179/219) of patients. The mean delay to the second symptom was 2.9±2.2 years. International classifications were not concordant with the expert classification. Our paediatric classification contains six categories, a minimum of three signs (each in a distinct category) defining paediatric BD. Three clinical signs discriminated our cohort from the Eurofever cohorts.
Interpretation: We present a comprehensive description of a large cohort of patients from both European and non-European countries and propose the first classification of paediatric BD for future therapeutic trials.
Keywords: Behcet's disease; Epidemiology; Fever Syndromes.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Similar articles
-
Validation of the PEDiatric Behçet's Disease classification criteria: an evidence-based approach.Rheumatology (Oxford). 2024 Dec 1;63(12):3422-3431. doi: 10.1093/rheumatology/kead609. Rheumatology (Oxford). 2024. PMID: 37991850 Free PMC article.
-
The performance of different classification criteria in paediatric Behçet's disease.Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):119-123. Epub 2017 Apr 5. Clin Exp Rheumatol. 2017. PMID: 28406761
-
Diagnostic/classification criteria in pediatric Behçet's disease.Rheumatol Int. 2019 Jan;39(1):37-46. doi: 10.1007/s00296-018-4208-9. Epub 2018 Nov 14. Rheumatol Int. 2019. PMID: 30430200 Review.
-
Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.Acta Dermatovenerol Croat. 2017 Dec;25(4):295-297. Acta Dermatovenerol Croat. 2017. PMID: 30064603
-
Behçet's disease in children, an overview.Pediatr Rheumatol Online J. 2016 Feb 18;14(1):10. doi: 10.1186/s12969-016-0070-z. Pediatr Rheumatol Online J. 2016. PMID: 26887984 Free PMC article. Review.
Cited by
-
Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network.Intern Emerg Med. 2021 Nov;16(8):2163-2171. doi: 10.1007/s11739-021-02725-9. Epub 2021 Apr 9. Intern Emerg Med. 2021. PMID: 33835406 Free PMC article.
-
Genetic and immunologic findings in children with recurrent aphthous stomatitis with systemic inflammation.Pediatr Rheumatol Online J. 2021 May 10;19(1):70. doi: 10.1186/s12969-021-00552-y. Pediatr Rheumatol Online J. 2021. PMID: 33971891 Free PMC article.
-
Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry.Intern Emerg Med. 2023 Apr;18(3):743-754. doi: 10.1007/s11739-023-03215-w. Epub 2023 Mar 7. Intern Emerg Med. 2023. PMID: 36881285 Free PMC article. Clinical Trial.
-
Systemic autoinflammatory diseases in pediatric population.Asia Pac Allergy. 2022 Jul 18;12(3):e29. doi: 10.5415/apallergy.2022.12.e29. eCollection 2022 Jul. Asia Pac Allergy. 2022. PMID: 35966154 Free PMC article.
-
Colchicine - an effective treatment for children with a clinical diagnosis of autoinflammatory diseases without pathogenic gene variants.Pediatr Rheumatol Online J. 2021 Sep 14;19(1):142. doi: 10.1186/s12969-021-00588-0. Pediatr Rheumatol Online J. 2021. PMID: 34521435 Free PMC article.